SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001193125-23-140755
Filing Date
2023-05-10
Accepted
2023-05-10 16:20:31
Documents
14
Period of Report
2023-05-10
Items
Item 2.02: Results of Operations and Financial Condition
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K d425606d8k.htm   iXBRL 8-K 24842
2 EX-99.1 d425606dex991.htm EX-99.1 93211
6 GRAPHIC g425606g0510233024428.jpg GRAPHIC 5423
  Complete submission text file 0001193125-23-140755.txt   261752

Data Files

Seq Description Document Type Size
3 XBRL TAXONOMY EXTENSION SCHEMA ino-20230510.xsd EX-101.SCH 2845
4 XBRL TAXONOMY EXTENSION LABEL LINKBASE ino-20230510_lab.xml EX-101.LAB 17995
5 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE ino-20230510_pre.xml EX-101.PRE 11259
8 EXTRACTED XBRL INSTANCE DOCUMENT d425606d8k_htm.xml XML 3356
Mailing Address 6769 MESA RIDGE RD. SAN DIEGO CA 92121
Business Address 6769 MESA RIDGE RD. SAN DIEGO CA 92121 8584103134
INOVIO PHARMACEUTICALS, INC. (Filer) CIK: 0001055726 (see all company filings)

IRS No.: 330969592 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-14888 | Film No.: 23906716
SIC: 3841 Surgical & Medical Instruments & Apparatus